All Stories

  1. Trends in adrenal cancer mortality in the US: Regional, demographic and geographic disparities from 1999 to 2020
  2. HCV genotyping and rational computational designing of an immunogenic multiepitope vaccine against genotype 3a
  3. Development of a Multiple Epitopes‐Based Dengue Vaccine: An Immunoinformatics Approach and Insights From Pakistani Population Genetics
  4. LncRNA HULC and LncRNA HOTAIR expression profile are strong predictors of direct antiviral agents therapy response in chronic Hepatitis C Virus-infected patients
  5. Exploring HPV-linked head and neck cancer in Southern Punjab, Pakistan: Insights from HPV-16 phylogenetic analysis
  6. Polymorphisms in IL-10- and IL-22-Binding Protein Genes as Genetic Predictors of the Direct-Acting Antivirals Treatment Response in Patients with Chronic Hepatitis C Virus
  7. Mammalian Cell Expression of a Fully Functional Recombinant E6 Protein Encoded by HPV16 Isolate from Pakistani Population
  8. Phylogenetic Analysis of E6 and E7 Gene of Human Papillomavirus 16 Variants Isolated from Pakistani Population
  9. The emerging role of epigenetics (DNA methylation) in hepatitis C virus-induced hepatocellular carcinoma
  10. Molecular epidemiology and genetic characterization of hepatitis B virus in two major provinces of Pakistan
  11. Computational prediction of a phage cocktail active against multidrug-resistant bacteria
  12. Coincidence of HCV and chronic kidney disease-a systematic review and meta-analysis
  13. The Factors Associated With Mutant Epidermal Growth Factor Receptor Positivity in Patients With Lung Cancer: A Study From a Tertiary Care Center in Pakistan
  14. Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology
  15. Improving Access to Anti-HDV Testing: Development and Validation of an Affordable In-House ELISA Assay
  16. Exploring the Concordance Between High-Risk Human Papillomavirus Infections in Cervical and Oral Sites Among Females: A Cross-Sectional Study in Punjab, Pakistan
  17. Assessment of ubiquitin specific Peptidase-18 gene in peripheral blood of chronic hepatitis C patients treated with direct-acting antiviral drugs
  18. A Comparative Analysis of Baseline Variables in Responder and Non-Responder Groups of Chronic Hepatitis C patients
  19. Potential Role of Recombinant Capsid Protein of Dengue Virus Serotype 2 in the Development of an In-House Elisa Based Detection of Infection
  20. Quasispecies Analysis Through NGS and Identification of Escape Mutation in a Family Infected with Hepatitis B Virus: A Study from Lahore, Pakistan
  21. An ncRNA transcriptomics-based approach to design siRNA molecules against SARS-CoV-2 double membrane vesicle formation and accessory genes
  22. Whole-genome analysis and evolutionary characterization of cervical and oral human papillomavirus 16
  23. Harnessing Nature’s Gifts:Salix nigraand Its Potential for Combating Hepatitis C Virus (HCV)
  24. Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic
  25. Expression Profiling of the Tripartite Motif Family Genes in Chronic Hepatitis C Patients
  26. Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosis
  27. Transcriptional Analysis of TP53 Gene in Chronic Hepatitis C Patients Treated with Sofosbuvir, Daclatasvir, Pegylated Interferon, and Ribavirin
  28. Structural Analysis and Epitope Prediction of S2 Domain of SARS-CoV-2, Conservation Analysis Among Major Variants
  29. The History and Current Killings of Polio Vaccinators in Pakistan: A Need for Targeted Surveillance Strategy
  30. Genotypic distribution of human papillomavirus and phylogenetic analysis of E6 and E7 gene of HR-HPV variants isolated from Pakistani population
  31. Frequency of Hepatitis D Viral Infection in Chronic Hepatitis B Patients in Pakistan
  32. Identification of Predictive Factors in Chronic Hepatitis C Patients with Non-Infected Individuals: A Comparative Analysis
  33. Methanolic Extract of Neem Plant Inhibits NS3 and NS5A Nonstructural Proteins of HCV 3A Genotype
  34. An Immunoinformatics Approach to Design a Potent Multi-Epitope Vaccine against Asia-1 Genotype of Crimean–Congo Haemorrhagic Fever Virus Using the Structural Glycoproteins as a Target
  35. A review on hepatitis C virus: role of viral and host-cellular factors in replication and existing therapeutic strategies
  36. Adenovirus Vector System: Construction, History and Therapeutic Applications
  37. Molecular characterization of recombinant premembrane protein of dengue virus serotype‐2 for development of diagnostic assay
  38. Hepatitis C virus transmission cluster among injection drug users in Pakistan
  39. Molecular characterization and risk factors of oral high‐risk human papillomavirus among females in Punjab, Pakistan
  40. P2X4 receptors mediate induction of antioxidants, fibrogenic cytokines and ECM transcripts; in presence of replicating HCV in in vitro setting: An insight into role of P2X4 in fibrosis
  41. Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic
  42. A review on corona virus pandemic: Update on epidemiology, diagnosis, and treatment
  43. HLA Polymorphism in Punjabi Population of Pakistan
  44. Insights into the Structure, Replication, and Pathogenesis of the Severe Acute Respiratory Syndrome Coronavirus 2
  45. Bacterial Expression and Purification of Antigenic Recombinant Protein Encoded by Hepatitis Delta Virus Antigen of Pakistani Isolate
  46. Patient with Suspected COVID-19 Infection Tests Negative in Nasopharyngeal Swabs but is Confirmed by Laboratory Tests and Chest CT Scan: A Case Report
  47. Current Status of Therapeutic Approaches and Vaccines for SARS-CoV-2
  48. Next-generation sequencing studies on the E1-HVR1 region of hepatitis C virus (HCV) from non-high-risk HCV patients living in Punjab and Khyber Pakhtunkhwa, Pakistan
  49. Cytokine storm syndrome in SARS-CoV-2: a review
  50. Early detection of MDR Mycobacterium tuberculosis mutations in Pakistan
  51. Distribution of High-risk Human Papillomavirus Genotypes in Cervical Secretions in Punjab
  52. MMTV-LIKE virus and c-myc over-expression are associated with invasive breast cancer
  53. Seroprevalence of SARS-CoV-2 in Pakistan: an update on epidemiological trends
  54. CRISPR-Cas13a mediated targeting of hepatitis C virus internal-ribosomal entry site (IRES) as an effective antiviral strategy
  55. Identification and expression analysis of antigenic sites of hepatitis C virus genotype 3a NS3 and NS5A genes of local isolate
  56. p53 and rb Promoter Methylation in Hepatitis C virus-related Chronic Hepatitis and Hepatocellular Carcinoma
  57. Dengue Vaccines: Ongoing Challenges and Current Status in the Advancement of Different Candidates
  58. Novel Coronavirus: A Review from Origin to Current Status of Therapeutic Strategies
  59. Genome‐wide methylation profiling of HCV pathogenesis to develop diabetes and diabetic complications
  60. Association of dupA, iceA, homB Genes of Helicobacter pylori with Gastritis, Peptic Ulcer Disease and Gastric Cancer
  61. Peripheral Expression ofCXCL10Gene in Chronic Hepatitis C Patients Treated with Sofosbuvir, Daclatasvir, and Ribavirin
  62. Comparing the risk of hypothyroidism in HCV patients treated with different DAA drugs combinations (sofosbuvir + interferon + ribavirin and sofosbuvir + daclatasvir + ribavirin)
  63. Blood-based gene expression profile of oxidative stress and antioxidant genes for identifying surrogate markers of liver tissue injury in chronic hepatitis C patients
  64. Applications and hazards associated with carbon nanotubes in biomedical sciences
  65. Advancements in Developing an Effective and Preventive Dengue Vaccine
  66. Expression of TRIM22 mRNA in chronic hepatitis C patients treated with direct‐acting antiviral drugs
  67. Association of Interleukin 28B Polymorphism with Clearance of Hepatitis C Virus: A Mini Review
  68. Cervical cancer vaccination awareness and acceptance among the females of Punjab, Pakistan
  69. Drug Resistance in Hepatitis C Virus: Future Prospects and Strategies to Combat It
  70. Paradoxical Role of Dengue Virus Envelope Protein Domain III Antibodies in Dengue Virus Infection
  71. Prevalence and Upcoming Threats of Chikungunya Virus in Pakistani Population
  72. Role of MicroRNAs in Establishing Latency of Human Immunodeficiency Virus
  73. Herpes Simplex Virus Type 1 and Host Antiviral Immune Responses: An Update
  74. A novel avian isolate of hepatitis E virus from Pakistan
  75. Characterization of Hepatitis Delta Virus Among Pregnant Women of Pakistan
  76. Sequence Variability of HCV 3a Isolates Based On Core Gene in Patients From Lahore, Pakistan
  77. Cosmopolitan A1 lineage of dengue virus serotype 2 is circulating in Pakistan: A study from 2017 dengue viral outbreak
  78. Scoping Review of Crimean-Congo Hemorrhagic Fever (CCHF) Literature and Implications of Future Research
  79. In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors
  80. Advances in the role of HCV nonstructural protein 5a (NS5A) of 3a genotype in inducing insulin resistance by possible phosphorylation of AKT/PKB
  81. Short article: Hepatitis C and G virus coinfection in Punjab, Pakistan: incidence and its correlation analysis with clinical data
  82. The interplay between viruses and TRIM family proteins
  83. Comparative Analysis of Immunological and Genomic Outcomes of Dengue Virus Outbreak in Pakistan
  84. HSV-1 Infection: Role of Viral Proteins and Cellular Receptors
  85. Molecular Detection of Hepatitis E Virus in Layer Chickens: A Possible Public Health Risk in Pakistan
  86. Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis
  87. Evolution of efficacious pangenotypic hepatitis C virus therapies
  88. Complete Genome Amplification and Sequencing of DENV-2 Pakistani Isolates: Analysis Reveals Molecular Evolution of DENV-2
  89. Recent trends in molecular epidemiology of Hepatitis C virus in Mardan, KPK Pakistan
  90. Perspectives towards antiviral drug discovery against Ebola virus
  91. Genetic diversity of Hepatitis C Virus in Pakistan using Next Generation Sequencing
  92. Prevalence of thyroid stimulating hormone dysfunction among sofosbuvir‐treated HCV‐infected patients: A real‐world clinical experience
  93. Tattooing trend: major cause of HCV transmission among youngsters
  94. Molecular epidemiology of hepatitis delta and hepatitis B viruses circulating in two major provinces (East and North-West) of Pakistan
  95. Biomarkers for diagnosis of pre-eclampsia and endometriosis
  96. An Overview of Cancer Immunotherapeutic Strategies
  97. Poor glycemic control and abrupt onset of diabetes in HCV patients receiving direct-acting antiviral drugs: case series
  98. Unexpected Response Profiles Seen in Hepatitis C Virus-Infected Patients Treated with Sofosbuvir Plus Ribavirin: Five Case Reports
  99. Study of promoter hypomethylation profiles of RAS oncogenes in hepatocellular carcinoma derived from hepatitis C virus genotype 3a in Pakistani population
  100. Poor response to direct-acting antiviral therapy in HCV-infected elderly population: a real-life cohort study based on GeneXpert® technology
  101. Explosive Rise in Viral Infections Through Meat-Sellers
  102. Expression of SOCS1 and SOCS3 Genes in Interferon-Treated and Direct-Acting Antiviral Drugs-Treated Hepatitis C Patients
  103. Role of altered immune cells in liver diseases: a review
  104. Successful treatment of HCV/TB co-infected patient with sofosbuvir and daclatasvir: a case report
  105. Cloning and expression of NS3 gene of Pakistani isolate type 2 dengue virus
  106. Calculation of Wiener Indices of Thiazolides: The Potent Inhibitors of Hepatitis B Virus and Hepatitis C Virus Replication
  107. An Increase in Expression of SOCS1 Gene with Increase in Hepatitis C Virus Viral Load
  108. Genetic Diversity of Mycobacterium tuberculosis Complex Prevailing In Khyber Pakhtunkhwa, Pakistan
  109. An updated systematic review of Zika virus-linked complications
  110. Zika virus: Is Pakistan next?
  111. Polymerase Chain Reaction-Based Detection Method Is Suitable for Dengue Infection During Epidemics
  112. Adsorption of copper (II) by using derived-farmyard and poultry manure biochars: Efficiency and mechanism
  113. Role of circulatory microRNAs in the pathogenesis of hepatitis C virus
  114. Selected hepatoprotective herbal medicines: Evidence from ethnomedicinal applications, animal models, and possible mechanism of actions
  115. Thirty years of HIV in Pakistan: a systematic review of prevalence and current scenario
  116. Current status of therapeutic and vaccine approaches against Zika virus
  117. Therapeutic Strategies of Clustered Regularly Interspaced Palindromic Repeats-Cas Systems for Different Viral Infections
  118. Molecular detection of Isoniazid, Rifampin and Ethambutol resistance to M. tuberculosis and M. bovis in multidrug resistant tuberculosis (MDR-TB) patients in Pakistan
  119. Prevalence of hepatitis-C virus genotypes and potential transmission risks in Malakand Khyber Pakhtunkhwa, Pakistan
  120. Preservation of truncal genomic alterations in clear cell and papillary renal cell carcinomas with sarcomatoid features: An intra- and intertumoral, multifocal fluorescence in situ hybridization analysis reveals limited genetic heterogeneity
  121. Rising relapse rate in hepatitis C virus type 3a-infected patients against sofosbuvir and ribavirin combination therapy: a Pakistani experience
  122. Evaluation of three techniques for detection of IL28B SNP: A prognostic tool for HCV treatment outcome
  123. Emerging Viral Infections in Pakistan: Issues, Concerns, and Future Prospects
  124. Prevalence and Molecular Detection of Dengue Virus in 2013 Outbreak in KPK and Punjab, Pakistan
  125. Forensic applications of Y chromosomal properties
  126. Global expansion of chikungunya virus: mapping the 64-year history
  127. Erratum: Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins
  128. Advances in research on Zika virus
  129. Causes of deafness in the Punjab region of Pakistan and the role of consanguinity
  130. HCV-induced regulatory alterations of IL-1β, IL-6, TNF-α, and IFN-ϒ operative, leading liver en-route to non-alcoholic steatohepatitis
  131. Recent Trends in Electrochemical Detection of NH3, H2S and NOx Gases
  132. Study of inhibition of interferon inducible genes by dephosphorylation of E2 envelope gene of HCV genotype 1a
  133. New Insights into the Epigenetics of Hepatocellular Carcinoma
  134. Aedes aegypti is the Major Vector for Transmission of Dengue Virus in Lahore, Pakistan
  135. A systematic review of treatment response rates in Pakistani hepatitis C virus patients; current prospects and future challenges
  136. Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins
  137. Immunotherapeutic strategies for sexually transmitted viral infections: HIV, HSV and HPV
  138. Influence of Hepatitis B Virus Genetic Heterogeneity on Treatment Response Against Lamivudine and Interferon in Pakistani Isolates
  139. Circulating serotypes of dengue virus and their incursion into non-endemic areas of Pakistan; a serious threat
  140. Detection of Anti-Hepatitis B Virus Drug Resistance Mutations Based on Multicolor Melting Curve Analysis
  141. Zika: As an emergent epidemic
  142. Construction of Mammalian Expression Vector of Core Gene of HCV of Pakistani Isolate Genotype 1a
  143. Genetic distribution of 15 autosomal STR markers in the Punjabi population of Pakistan
  144. Prediction and conservancy analysis of promiscuous T-cell binding epitopes of Ebola virus L protein: An in silico approach
  145. Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients
  146. Complete genome sequencing and comparative analysis of three dengue virus type 2 Pakistani isolates
  147. Introduction and evolution of dengue virus type 2 in Pakistan: a phylogeographic analysis
  148. Genomic analysis of codon usage shows influence of mutation pressure, natural selection, and host features on Marburg virus evolution
  149. Deep sequencing shows microRNA expression in hepatitis C patients is associated with the end treatment response
  150. Association of aplastic anaemia with positive viral hepatitis serology, and its outcome after immunosuppressive therapy
  151. Development of Global Consensus of Dengue Virus Envelope Glycoprotein for Epitopes Based Vaccine Design
  152. Phylogenetic and 2D/3D Analysis of HCV 1a NS4A Gene/Protein in Pakistani Isolates
  153. The genotype CC ofIL-28B SNP rs12979860 is significantly associated with a sustained virological response in chronic HCV-infected Pakistani patients
  154. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays
  155. P0701 : Next generation sequencing reveals differential expression profiles of hepatic micrornas in chronic hepatitis C patients
  156. Computational Prediction and Analysis of Envelop Glycoprotein Epitopes of DENV-2 and DENV-3 Pakistani Isolates: A First Step towards Dengue Vaccine Development
  157. Evidence-based consensus on the diagnosis, prevention and management of hepatitis C virus disease
  158. Development and Validation of a New Spectrophotometric Method for the Determination of Cephalexin Monohydrate in Pure Form and Pharmaceutical Formulations
  159. Genetic history of hepatitis C virus in Pakistan
  160. P22: Identification and expression profiling of microRNAs in hepatitis C patients by using next generation sequencing
  161. Studies on the role of NS3 and NS5A non-structural genes of hepatitis C virus genotype 3a local isolates in apoptosis
  162. Prevalence and Molecular Determination of Hepatitis C Infection in Khyber Pakhtunkhwa, Pakistan
  163. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients
  164. Hepatitis delta virus genotype-1 alone cocirculates with hepatitis B virus genotypes A and D in Pakistan
  165. Studies on the role of neutralizing antibodies against envelope genes in resolving HCV pseudo-particles infection
  166. Generation of infectious HCV pseudo typed particles and its utilization for studying the role of CD81 & SRBI receptors in HCV infection
  167. Emergence of genetically variant Hepatitis C virus population in response to increased antiviral drug pressure, Pakistan
  168. Molecular Detection of Giardia lamblia and Cryptosporidium parvum in Different Water Sources of District Bannu, Khyber Pakhtunkhwa, Province of Pakistan
  169. Determination of hepatitis C virus genotypes circulating in different districts of Punjab (Pakistan)
  170. Inhibitory effect of kaolin minerals compound against hepatitis C virus in Huh-7 cell lines
  171. De Novo modeling of Envelope 2 protein of HCV isolated from Pakistani patient and epitopes prediction for vaccine development
  172. Change in demographic pattern of dengue virus infection: evidence from 2011 dengue outbreak in Punjab, Pakistan
  173. Tourism–growth nexus in Pakistan: Evidence from ARDL bounds tests
  174. Seroepidemiology of dengue fever in Khyber Pakhtunkhawa, Pakistan
  175. The first complete genome sequence of HCV-1a from Pakistan and a phylogenetic analysis with complete genomes from the rest of the world
  176. Mutations in the NS5A gene are associated with response to interferon+ribavirin combination therapy in patients with chronic hepatitis C virus 3a infection
  177. Modeling the impact of education on the economic growth: Evidence from aggregated and disaggregated time series data of Pakistan
  178. Prevalence of HBV infection in suspected population of conflict-affected area of war against terrorism in North Waziristan FATA Pakistan
  179. Dengue Virus Serotype 2 (DEN-2): the Causative Agent of 2011-Dengue Epidemic in Pakistan
  180. Computational identification of interplay between phosphorylation and O-β-glycosylation of human occludin as potential mechanism to impair hepatitis C virus entry
  181. Hepatitis E virus-associated aplastic anaemia: The first case of its kind
  182. Computational Identification and Modeling of Crosstalk between Phosphorylation, O-β-glycosylation and Methylation of FoxO3 and Implications for Cancer Therapeutics
  183. Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studie
  184. Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studies
  185. Mycoplasma genitalium: A comparative genomics study of metabolic pathways for the identification of drug and vaccine targets
  186. PCR could be a method of choice for identification of both pulmonary and extra-pulmonary tuberculosis
  187. High baseline interleukine-8 level is an Independent risk factor for the achievement of sustained virological response in chronic HCV patients
  188. Mixed Genotype Infections with Hepatitis C Virus, Pakistan
  189. An overview of Triple infection with Hepatitis B, C and D viruses
  190. Expression of core antigen of HCV genotype 3a and its evaluation as screening agent for HCV infection in Pakistan
  191. Comparative sequence, antigenic and phylogenetic analysis of avian influenza (H9N2) surface proteins isolated in Pakistan between 1999 and 2008
  192. The prevalence of HBV infection in the cohort of IDPs of war against terrorism in Malakand Division of Northern Pakistan
  193. Role of post translational modifications and novel crosstalk between phosphorylation and O-beta-GlcNAc modifications in human claudin-1, -3 and -4
  194. Evaluation of three different hepatitis C virus typing methods for detection of mixed-genotype infections
  195. Occult hepatitis C virus infection and associated predictive factors: The Pakistan experience
  196. Envelope 2 protein phosphorylation sites S75 & 277 of hepatitis C virus genotype 1a and interferon resistance: A sequence alignment approach
  197. Promiscuous prediction and conservancy analysis of CTL binding epitopes of HCV 3a viral proteome from Punjab Pakistan: an In Silico Approach
  198. An overview of treatment response rates to various anti-viral drugs in Pakistani Hepatitis B Virus infected patients
  199. Human herpesvirus 6 major immediate early promoter has strong activity in T cells and is useful for heterologous gene expression
  200. Change in hepatitis C virus clades: A cross-sectional study of chronic HCV patients in Pakistan from 2000–2010
  201. Isolation and characterization of two new hepatitis E virus genotype 1 strains from two mini-outbreaks in Lahore, Pakistan
  202. Hepatitis G Virus associated aplastic anemia: A recent case from Pakistan
  203. Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer
  204. True prevalence of twin HDV-HBV infection in Pakistan: a molecular approach
  205. Positional effect of phosphorylation sites 266 and 267 in the cytoplasmic domain of the E2 protein of hepatitis C virus 3a genotype: Interferon Resistance analysis via Sequence Alignment
  206. Hepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan
  207. Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan
  208. Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan
  209. Characterization of Hepatitis C Virus genotype 3a Hypervariable region 1 in patients achieved rapid virological response to alpha interferon and Ribavirin Combination therapy
  210. Hepatitis B virus in Pakistan: A systematic review of prevalence, risk factors, awareness status and genotypes
  211. Establishment of stable Huh-7 cell lines expressing various hepatitis C virus genotype 3a protein: an in-vitro testing system for novel anti-HCV drugs
  212. Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
  213. Hepatitis Associated Aplastic Anemia: A review
  214. Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini outbreaks-2007-2009 in Pakistan
  215. Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein
  216. Identification of ionotrophic purinergic receptors in Huh-7 cells and their response towards structural proteins of HCV genotype 3a
  217. Pattern and molecular epidemiology of Hepatitis B virus genotypes circulating in Pakistan
  218. The changing epidemiology pattern and frequency distribution of hepatitis C virus in Pakistan
  219. Simultaneous Amplification of Two Bacterial Genes: More Reliable Method of Helicobacter pylori Detection in Microbial Rich Dental Plaque Samples
  220. Prevalence of active hepatitis c virus infection in district mansehra pakistan
  221. Molecular epidemiology of Hepatitis C virus genotypes in Khyber Pakhtoonkhaw of Pakistan
  222. Prevalence of hepatitis delta virus infection among hepatitis b virus surface antigen positive patients circulating in the largest province of pakistan
  223. Mutations in the E2-PePHD region of hepatitis C virus genotype-3a and correlation with response to interferon and ribavirin combination therapy in Pakistani patients
  224. Hepatitis C Treatment: current and future perspectives
  225. Avian influenza A (H9N2): computational molecular analysis and phylogenetic characterization of viral surface proteins isolated between 1997 and 2009 from the human population
  226. Nucleotide identity and variability among different Pakistani hepatitis C virus isolates
  227. A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients
  228. Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience
  229. Development of an improved genotyping assay for the detection of hepatitis C virus genotypes and subtypes in Pakistan
  230. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission
  231. High prevalence of hepatitis C virus infection in the largest province of Pakistan
  232. Failure of Zooprophylaxis: Cattle Ownership Increase Rather than Reduce the Prevalence of Malaria in District Dir, N.W.F.P. of Pakistan
  233. Squeezed states in a multiphoton absorption process